Trial Profile
Phase II Study of Antineoplastons A19 and AS2-1 in Patients With Neurofibroma and Schwannoma
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2017
Price :
$35
*
At a glance
- Drugs Antineoplaston A10/antineoplaston AS2-1 (Primary)
- Indications Neurilemmoma; Neurofibroma
- Focus Therapeutic Use
- 13 Dec 2016 New trial record